NIH supports later-stage research and development for previously funded small business Phase II projects, bridging the gap to commercialization.
Supports U.S. small businesses in bringing scientific innovations to market through feasibility studies and later research and development, with clinical trials optional.
The NSF SBIR/STTR Phase IIB supplement matches external capital to help Phase II awardees accelerate R&D and commercialization of innovative technologies.
Phase I grants support small businesses in testing the feasibility of research and development ideas that could improve the lives of people with disabilities; 11 six-month grants are available.
SBIR/STTR Phase I, Phase II, and Fast-Track Programs support startups and small businesses developing high-risk deep technologies into commercial products and services to advance U.S. competitiveness and security.
Four 24-month Phase II grants support small businesses developing products that improve health, community living, or employment outcomes for people with disabilities.